|
|
|
Volumn 19, Issue 13, 2005, Pages
|
|
EGFR inhibitors in lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
GEFITINIB;
QUINAZOLINE DERIVATIVE;
CONTROLLED CLINICAL TRIAL;
DRUG ANTAGONISM;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
PATIENT SELECTION;
REVIEW;
TREATMENT FAILURE;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CONTROLLED CLINICAL TRIALS;
HUMANS;
LUNG NEOPLASMS;
PATIENT SELECTION;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
TREATMENT FAILURE;
|
|
EID: 33644854733
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (22)
|
|
References (46)
|
